Skip to main content

Advertisement

Log in

Two Unusual Cases of Diffuse Acrodermatitis Chronica Atrophicans Seronegative for Lyme Borreliosis

  • Brief Report
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

References

  1. Asbrink E, Hovmark A, Hederstedt B (1984) The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol 64:506–512

    CAS  PubMed  Google Scholar 

  2. Plorer A, Sepp N, Schmutzhard E, Krabichler S, Trobos S, Schauer G (1993) Effects of adequate versus inadequate treatment of cutaneous manifestations of Lyme borreliosis on the incidence of late complications and late serologic status. J Invest Dermatol 100:103–109

    CAS  PubMed  Google Scholar 

  3. Koning J de, Tazelaar DJ, Hoogkamp-Korstanje JA, Elema JD (1995) Acrodermatitis chronica atrophicans: a light and electron microscopic study. J Cutan Pathol 22:23–32

    PubMed  Google Scholar 

  4. Asbrink E (1985) Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes. Acta Derm Venereol 18 (Suppl 1):1–63

    Google Scholar 

  5. Asbrink E, Hovmark A, Olsson I (1986) Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients. Zentralbl Bakteriol Mikrobiol Hyg 263:253–261

    CAS  Google Scholar 

  6. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ (1987) Lyme disease in Europe and North America. Lancet 1:681

    Google Scholar 

  7. Ryffel K, Peter O, Rutti B, Suard A, Dayer E (1999) Scored antibody reactivity determined by immunoblotting shows an association between clinical manifestations and presence of Borrelia burgdorferi sensu stricto, B. garinii, B. afzelii, and B. valaisiana in humans. J Clin Microbiol 37:4086–4092

    CAS  PubMed  Google Scholar 

  8. Wienecke R, Zochling N, Neubert U, Schlupen EM, Meurer M, Volkenandt M (1994) Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans. J Invest Dermatol 103:19–22

    CAS  PubMed  Google Scholar 

  9. Asbrink E, Brehmer-Andersson E, Hovmark A (1986) Acrodermatitis chronica atrophicans—a spirochetosis. Clinical and histopathological picture based on 32 patients; course and relationship to erythema chronicum migrans Afzelius. Am J Dermatopathol 8:209–219

    CAS  PubMed  Google Scholar 

  10. Robertson J, Guy E, Andrews N, Wilske B, Anda P, Granstrom MA (2000) European multicenter study of immunoblotting in serodiagnosis of lyme borreliosis. J Clin Microbiol 38:2097–2102

    CAS  PubMed  Google Scholar 

  11. Huppertz HI, Schmidt H, Karch H (1993) Detection of Borrelia burgdorferi by nested polymerase chain reaction in cerebrospinal fluid and urine of children with neuroborreliosis. Eur J Pediatr 152:414–417

    CAS  PubMed  Google Scholar 

  12. Marconi RT, Garon CF (1992) Development of polymerase chain reaction primer sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis. J Clin Microbiol 30:2830–2834

    PubMed  Google Scholar 

  13. Asbrink E, Hovmark A, Hederstedt B (1985) Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme-linked immunosorbent assays. Acta Derm Venereol 65:509–514

    CAS  PubMed  Google Scholar 

  14. Luft BJ, Dattwyler RJ, Johnson RC, Luger SW, Bosler EM, Rahn DW (1996) Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial. Ann Intern Med 124:785–791

    CAS  PubMed  Google Scholar 

  15. Hardin JA, Steere AC, Malawista SE (1979) Immune complexes and the evolution of Lyme arthritis. Dissemination and localization of abnormal C1q binding activity. N Engl J Med 301:1358–1363

    CAS  PubMed  Google Scholar 

  16. Schutzer SE, Coyle PK, Reid P, Holland B (1999) Borrelia burgdorferi-specific immune complexes in acute Lyme disease. JAMA 282:1942–1946

    Article  CAS  PubMed  Google Scholar 

  17. Brunner M, Sigal LH (2001) Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferi. J Clin Microbiol 39:3213–3221

    Article  CAS  PubMed  Google Scholar 

  18. Schutzer SE, Natelson BH (1999) Absence of Borrelia burgdorferi-specific immune complexes in chronic fatigue syndrome. Neurology 53:1340–1341

    CAS  PubMed  Google Scholar 

  19. Wang P, Hilton E (2001) Contribution of HLA alleles in the regulation of antibody production in Lyme disease. Front Biosci 6:10–16

    Google Scholar 

Download references

Acknowledgement

This work was supported by the IZKF grant A2.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Gessner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berger, T.G., Schoerner, C., Schell, H. et al. Two Unusual Cases of Diffuse Acrodermatitis Chronica Atrophicans Seronegative for Lyme Borreliosis. Eur J Clin Microbiol Infect Dis 22, 392–395 (2003). https://doi.org/10.1007/s10096-003-0943-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-003-0943-1

Keywords

Navigation